Skip to content

Category: Science Medical

NeuroScientific Biopharmaceuticals (ASX:NSB) Advances StemSmart(TM) Manufacturing Scale-Up as Phase 2 Crohn’s Disease Trial Preparations Progress

By

Perth, Australia – 17 March 2026 | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has reached an important development milestone with the commencement of the first technology transfer manufacturing run of its patented StemSmart™ mesenchymal stem cell (MSC) process at leading Australian cell therapy manufacturer Q-Gen Cell Therapeutics. The initiation of the manufacturing run represents a key step … Continued

New support for Australians impacted by CTE

By

Dementia Australia is proud to announce it has partnered with ConneCTErs Australia to expand the support available for people living with suspected or probable chronic traumatic encephalopathy (CTE) and their carers. As part of the federal government’s $12.4 million CTE Support and Prevention Program, Dementia Australia and ConneCTErs Australia will run a pilot program of … Continued

Monash Expert: Melbourne’s crown as innovation capital at risk

By

Melbourne’s innovation leadership didn’t happen by accident. And it won’t sustain itself without reasonable investment. In Future Campus, Professor Robyn Ward AM discusses why research investment, industry partnerships and strong innovation ecosystems are essential to keeping Melbourne competitive globally. Read more. Available to comment: Professor Robyn Ward AM, Deputy Vice-Chancellor (Research and Enterprise) and Senior Vice … Continued

Imprivata Introduces New Advanced Access Management and Passwordless Authentication Capabilities to Enhance Clinical Efficiency, Security, and Essential Eight Compliance

By

Imprivata Enterprise Access Management now offers facial recognition, AI-powered behavioral analytics, and high-assurance identity verification to further streamline clinical access, improve operational efficiency, and strengthen security posture MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) — Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today introduced comprehensive new capabilities designed to … Continued

RACGP calls for funding to support GPs delivering essential care during natural disasters

By

The Royal Australian College of GPs (RACGP) is calling on the Queensland Government to fund targeted measures that will strengthen Queensland’s frontline primary care response during natural disasters, ensuring communities receive safe, coordinated healthcare when it is needed most. Australians are experiencing the impacts of climate driven disasters more frequently and more intensely, with the … Continued

New report: La Niña failed to cool Victoria’s summer with record heat and fires

By

FOR IMMEDIATE RELEASE MARCH 17 2026 A new Climate Council report finds record global levels of coal, oil and gas pollution is overtaking natural climate drivers like El Niño and La Niña – accelerating the “climate whiplash” phenomenon that pushes communities rapidly from one disaster to the next.   The report Breakneck Speed: Summer of Climate … Continued

New report: Aussies flung from summer fires to floods in breakneck climate whiplash

By

FOR IMMEDIATE RELEASE – MARCH 17 2026 A new Climate Council report out today finds record global levels of coal, oil and gas pollution are overtaking natural climate drivers like El Niño and La Niña – accelerating the “climate whiplash” phenomenon that flings communities rapidly from one disaster to the next.   The report Breakneck Speed: Summer … Continued

SBC Medical Announces Opening of Brand Flagship “NEO Skin Clinic Ginza.”

By

 Accelerating multi-branding strategy in aesthetic healthcare with global presence in Tokyo’s premier district IRVINE, Calif.–BUSINESS WIRE– SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that its specialized aesthetic brand, “NEO Skin Clinic,” will open … Continued

Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide

By

Samsung Bioepis to receive exclusive license to develop and commercialize two novel assets including long-acting semaglutide using G2GBIO’s proprietary microsphere technology Epis NexLab, a sister company to Samsung Bioepis under Samsung Epis Holdings, also signs the agreement to collaborate in the development of the long-acting microsphere drug delivery platform INCHEON, Korea–BUSINESS WIRE– Samsung Bioepis Co., … Continued